SILK RD MED INC's ticker is SILK and the CUSIP is 82710M100. A total of 168 filers reported holding SILK RD MED INC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $551,838 | +159.7% | 36,813 | +463.0% | 0.00% | – |
| Q2 2023 | $212,458 | -65.8% | 6,539 | -52.7% | 0.00% | -100.0% |
| Q3 2022 | $622,000 | +23.4% | 13,821 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $504,000 | -8.2% | 13,840 | +4.1% | 0.00% | 0.0% |
| Q1 2022 | $549,000 | -4.2% | 13,290 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $573,000 | -47.2% | 13,440 | -31.8% | 0.00% | -50.0% |
| Q3 2021 | $1,085,000 | -23.7% | 19,709 | -33.7% | 0.00% | 0.0% |
| Q2 2021 | $1,422,000 | +1.9% | 29,717 | +7.9% | 0.00% | 0.0% |
| Q1 2021 | $1,396,000 | -14.6% | 27,550 | +6.2% | 0.00% | -33.3% |
| Q4 2020 | $1,634,000 | -7.7% | 25,943 | -1.5% | 0.00% | -25.0% |
| Q3 2020 | $1,770,000 | +180.1% | 26,335 | +74.6% | 0.00% | +300.0% |
| Q2 2020 | $632,000 | +98.1% | 15,079 | +48.9% | 0.00% | 0.0% |
| Q1 2020 | $319,000 | -84.5% | 10,126 | -80.1% | 0.00% | -75.0% |
| Q4 2019 | $2,052,000 | – | 50,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC | 399,483 | $25,159,000 | 1.77% |
| NEXT CENTURY GROWTH INVESTORS LLC | 313,534 | $19,746,000 | 1.66% |
| Graticule Asia Macro Advisors LLC | 52,565 | $3,311,000 | 1.59% |
| Bullseye Asset Management LLC | 58,112 | $3,659,000 | 1.36% |
| EMC Capital Management | 24,598 | $1,549,000 | 1.18% |
| Parkman Healthcare Partners LLC | 67,854 | $4,273,000 | 1.10% |
| Nicholas Investment Partners, LP | 219,483 | $13,823,000 | 1.07% |
| SCHOLTZ & COMPANY, LLC | 37,517 | $2,363,000 | 0.92% |
| WASATCH ADVISORS LP | 2,630,013 | $165,638,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 125,000 | $7,873,000 | 0.64% |